Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion‐driven non‐small cell lung cancer.
Saved in:
| Title: | Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion‐driven non‐small cell lung cancer. |
|---|---|
| Authors: | Desilets, Antoine1 (AUTHOR), Repetto, Matteo1,2 (AUTHOR), Drilon, Alexander1,3 (AUTHOR) drilona@mskcc.org |
| Source: | Clinical & Translational Medicine. Oct2024, Vol. 14 Issue 10, p1-5. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
